The SUCCEED Trial of Secondary Stroke Prevention
Status: | Active, not recruiting |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 40 - Any |
Updated: | 10/7/2018 |
Start Date: | September 2013 |
End Date: | January 2019 |
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
The purpose of this study is to test a newly-developed outpatient clinic and community-based
care intervention called SUCCEED (Secondary stroke prevention by Uniting Community and
Chronic care model teams Early to End Disparities) for improving control of stroke risk
factors among stroke patients in the Los Angeles County "safety net", and to measure the
costs of running such an intervention, relative to usual care.
care intervention called SUCCEED (Secondary stroke prevention by Uniting Community and
Chronic care model teams Early to End Disparities) for improving control of stroke risk
factors among stroke patients in the Los Angeles County "safety net", and to measure the
costs of running such an intervention, relative to usual care.
Individuals randomized to the intervention arm will receive care from a team that consists of
a care manager(CM) who is either a nurse practitioner (NP) or physician assistant (PA),
supervised by the site PI, and a community health worker (CHW). The CM will follow care
protocols developed by the research team. The CHW will serve as a liaison between the patient
and the health care system, and mobilize resources and system support to reduce social
isolation and improve stroke risk factor control self-management, through a series of
workshops and home visits. Intervention participants will receive home blood pressure
monitors. Subjects in either arm are eligible to receive their usual source of care. Five
hundred participants who have had a stroke or TIA will be enrolled, randomized to the
intervention or to usual care in a 1:1 ratio, and followed for 12 months. The impact of the
intervention on systolic blood pressure is the primary study outcome; secondary outcomes are
other stroke risk factors. Enrollment will occur at four sites in Los Angeles County, and the
study sample is projected to include over 90% socioeconomically disadvantaged individuals
from minority groups.
a care manager(CM) who is either a nurse practitioner (NP) or physician assistant (PA),
supervised by the site PI, and a community health worker (CHW). The CM will follow care
protocols developed by the research team. The CHW will serve as a liaison between the patient
and the health care system, and mobilize resources and system support to reduce social
isolation and improve stroke risk factor control self-management, through a series of
workshops and home visits. Intervention participants will receive home blood pressure
monitors. Subjects in either arm are eligible to receive their usual source of care. Five
hundred participants who have had a stroke or TIA will be enrolled, randomized to the
intervention or to usual care in a 1:1 ratio, and followed for 12 months. The impact of the
intervention on systolic blood pressure is the primary study outcome; secondary outcomes are
other stroke risk factors. Enrollment will occur at four sites in Los Angeles County, and the
study sample is projected to include over 90% socioeconomically disadvantaged individuals
from minority groups.
Inclusion Criteria:
- Patients of LAC+USC, Rancho Los Amigos, Olive View-UCLA, or Harbor-UCLA
- Transient ischemic attack (TIA), ischemic stroke or hemorrhagic stroke within the
prior 90 days
- English, Spanish, Korean, Mandarin or Cantonese-speaking
- 40 years of age or older
- Capable of giving informed consent (no proxies will be used to obtain consent)
- Systolic blood pressure is 130 mm Hg or greater OR Systolic blood pressure is between
120 mm Hg and 130 mm Hg and there is diagnosed/treated hypertension prior to the
stroke or TIA
Exclusion Criteria:
- Younger than 40 years
- Systolic Blood Pressure less than 120 mm Hg OR systolic blood pressure is between 120
mm Hg and 130 mm Hg and there is no known history of hypertension prior to the stroke
or TIA
- Speaks language other than English, Spanish, Korean, Mandarin, and Cantonese
- Inability to comprehend the study because of communication or cognitive impairments
We found this trial at
6
sites
Click here to add this to my saved trials
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
UCLA UCLA's primary purpose as a public research university is the creation, dissemination, preservation and...
Click here to add this to my saved trials
Click here to add this to my saved trials